Jennifer Schöning studies the effect of hypoxia on cancer stem cells and polymer based gene therapy treatments.

Using sphere culture to simulate tumour like micro environments inorder to study cancer stem cells in different degrees of hypoxia. Collaboration with polymer chemists to develop and use polymer based gene therapy to target cancer stem cells in hypoxic environments

Jennifer completed a Bachelor of Biotechnology from the Australian National University and received an first class honours in evolutionary and cancer genetics. She has worked in a wide variety of laboratories including diagnostic and research labs in public, private and academic organisations. Her last full time position was in cytogenetic diagnostics at the Royal Brisbane Hospital for Queensland Pathology. She has returned to studies to complete a PhD at the Australian Institute of Bioengineering and Nanotechnology at the University of Queensland.

Key Publications

​Schöning, J. P., Monteiro, M. and Gu, W. (2016), Drug resistance and cancer stem cells: the shared but distinct roles of hypoxia-inducible factors HIF1α and HIF2α. Clin Exp Pharmacol Physiol. Accepted Author Manuscript. doi:10.1111/1440-1681.12693